Biomedical Engineering Reference
In-Depth Information
7. Mauerer HH (2007) Current role of liquid chromatography-mass spectrometry in clinical and
forensic toxicology. Anal Bioanal Chem 388:1315-1325
8. Peters FT (2011) Recent advances of liquid chromatography-(tandem) mass spectrometry in
clinical and forensic toxicology. Clin Biochem 44:54-65
9. Kamel A, Prakash C (2006) High performance liquid chromatography/atmospheric pressure
ionization/tandem mass spectrometry (HPLC/API/MS/MS) in drug metabolism and toxicol-
ogy. Curr Drug Metab 7:837-852
10. Stokvis E, Rosing H, Beijnen JH (2005) Liquid chromatography-mass spectrometry for the
quantitative bioanalysis of anticancer drugs. Mass Spectrom Rev 24:887-917
11. Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, Müller-
Oerlinghausen B, Rao ML, Riederer P, Zernig G (2004) The AGNP-TDM expert group consensus
guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37:243-265
12. Vogeser M, Parhofer KG (2007) Liquid chromatography tandem-mass spectrometry (LC-MS/MS)
- technique and applications in endocrinology. Exp Clin Endocrinol Diabetes 115:555-570
13. Kushnir MM, Rockwood AL, Bergquist J (2010) Liquid chromatography-tandem mass spec-
trometry applications in endocrinology. Mass Spectrom Rev 29:480-502
14. Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle W (2011) Liquid chro-
matography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin
Biochem 44:77-88
15. Hoofnagle AN (2010) Quantitative clinical proteomics by liquid chromatography-tandem
mass spectrometry: assessing the platform. Clin Chem 56:161-164
16. Hortin GL (2005) Can mass spectrometric protein profiling meet desired standards of clinical
laboratory practice? Clin Chem 51:3-5
17. Carr SA, Anderson L (2008) Protein quantitation through targeted mass spectrometry: the way
out of biomarker purgatory? Clin Chem 54:1749-1752
18. Anderson NL (2010) The clinical plasma proteome: a survey of clinical assays for proteins in
plasma and serum. Clin Chem 56:177-185
19. Hoofnagle AN, Wener MH (2009) The fundamental flaws of immunoassays and potential
solutions using tandem mass spectrometry. J Immunol Methods 347:3-11
20. Hortin GL, Carr SA, Anderson NL (2010) Introduction: advances in protein analysis for the
clinical laboratory. Clin Chem 56:159-161
21. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM et al (2009) Multi-site
assessment of the precision and reproducibility of multiple reaction monitoring-based mea-
surements of proteins in plasma. Nat Biotechnol 27:633-641
22. Anderson L, Hunter CL (2006) Quantitative mass spectrometric multiple reaction monitoring
assays for major plasma proteins. Mol Cell Proteomics 5:573-588
23. Kumar V, Barnidge DR, Cheng LS, Twentyman JM, Cradic KW, Grebe SK, Singh RJ (2010)
Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by
immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin
Chem 56:306-313
24. Hoofnagle AN, Becker JO, Wener MH, Heinecke JW (2008) Quantification of thyroglobulin,
a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spec-
trometry. Clin Chem 54:1796-1804
25. Rodriguez-Cabaleiro D, van Uytfanghe K, Stove V, Fiers T, Thienpont LM (2007) Pilot study
for the standardization of insulin immunoassays with isotope dilution liquid chromatography/
tandem mass spectrometry. Clin Chem 53:1462-1469
26. Daniel YA, Turner C, Haynes RM, Hunt BJ, Dalton RN (2007) Quantification of hemoglobin
A2 by tandem mass spectrometry. Clin Chem 53:1448-1454
27. Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG (2007) LC-MS/MS quantification of
Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer. Clin Chem 53:673-678
28. Rauh M, Gröschl M, Rascher W (2007) Simultaneous quantification of ghrelin and desacyl-
ghrelin by liquid chromatography-tandem mass spectrometry in plasma, serum, and cell super-
natants. Clin Chem 53:902-910
